title: The treatment of congenital dacryocystocele.
abstract: OBJECTIVE
  To determine the proper management of congenital dacryocystocele.
  
  
  METHODS
  Retrospective interventional case series.
  
  
  METHODS
  
  
  
  METHODS
  Clinical practice.
  
  
  METHODS
  Twenty-seven consecutive patients with 29 congenital dacryocystoceles who presented from 1987 through 2006.
  
  
  METHODS
  The charts were reviewed for the presence and age of onset of infection, methods and age of treatment, and response to treatment.
  
  
  RESULTS
  Dacryocystitis and preseptal cellulitis requiring intravenous antibiotic therapy were present in 11 lacrimal systems (37.9%), and dacryocystitis without cellulitis was present in an additional 10 lacrimal systems (34.5%). One or more probings were performed in 26 patients (89.7%). Resolution with conservative therapy occurred in three lacrimal systems. The initial probing was successful in seven of seven lacrimal systems (100%) that did not have infection, but was successful in only 10 of 19 lacrimal systems (53%) that had dacryocystitis with or without cellulitis. The mean age of probing in the surgical patients who did not develop infection was 5.9 days, whereas the mean age at first probing in surgical patients who developed infection was 17.3 days.
  
  
  CONCLUSIONS
  Patients with congenital dacryocystocele should have probing on an urgent basis and as early in life as possible, unless the lacrimal sac decompresses into the nose at the time of the initial examination. This approach will reduce the incidence of dacryocystitis and cellulitis, and improve the success rate of surgery.
authors.affiliation: Jules Stein Eye Institute, Department of Ophthalmology, University of California Los Angeles School of Medicine, Los Angeles, California, USA. Brisbeee@aol.com
authors.forename: Bruce B
authors.initials: BB
authors.lastname: Becker
mesh_terms: D017668:Age of Onset; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000151:congenital / Q000601:surgery; D003607:Dacryocystitis / Q000151:congenital / Q000601:surgery; D003608:Dacryocystorhinostomy / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007767:Lacrimal Duct Obstruction / Q000151:congenital*; D008297:Male; D009301:Nasolacrimal Duct / Q000002:abnormalities* / Q000601:surgery*; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents